CRH Total Cost of Revenue decreased by 12.1% to $5.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.3%, from $4.92B to $5.33B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 5.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.84B | $4.84B | $4.84B | $5.48B | $5.48B | $5.48B | $5.48B | $4.81B | $6.08B | $6.37B | $5.73B | $4.73B | $5.98B | $6.46B | $5.71B | $4.92B | $6.18B | $6.76B | $6.06B | $5.33B |
| QoQ Change | — | +0.0% | +0.0% | +13.1% | +0.0% | +0.0% | +0.0% | -12.2% | +26.4% | +4.7% | -9.9% | -17.6% | +26.5% | +8.0% | -11.6% | -13.9% | +25.6% | +9.4% | -10.4% | -12.1% |
| YoY Change | — | — | — | — | +13.1% | +13.1% | +13.1% | -12.2% | +11.0% | +16.2% | +4.7% | -1.7% | -1.6% | +1.4% | -0.4% | +4.1% | +3.4% | +4.7% | +6.1% | +8.3% |